Bruker (NASDAQ:BRKR) Releases FY 2024 Earnings Guidance

Bruker (NASDAQ:BRKR) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 2.590-2.640 for the period, compared to the consensus earnings per share estimate of 2.640. The company issued revenue guidance of $3.4 billion-$3.4 billion, compared to the consensus revenue estimate of $3.4 billion. Bruker also updated its FY24 guidance to $2.59-2.64 EPS.

Bruker Stock Performance

Shares of NASDAQ BRKR traded down $1.32 during trading hours on Friday, reaching $62.00. 1,362,202 shares of the stock were exchanged, compared to its average volume of 1,034,237. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.91 and a current ratio of 1.81. The stock’s fifty day simple moving average is $64.22 and its 200 day simple moving average is $75.58. Bruker has a 52 week low of $53.79 and a 52 week high of $94.86. The firm has a market capitalization of $9.01 billion, a price-to-earnings ratio of 22.55, a P/E/G ratio of 2.39 and a beta of 1.20.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.52. Bruker had a net margin of 13.38% and a return on equity of 27.31%. The firm had revenue of $800.70 million during the quarter, compared to the consensus estimate of $799.44 million. During the same quarter in the previous year, the firm posted $0.50 EPS. The business’s revenue for the quarter was up 17.4% compared to the same quarter last year. Sell-side analysts predict that Bruker will post 2.66 EPS for the current year.

Bruker Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 17th. Stockholders of record on Monday, June 3rd were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend was Monday, June 3rd. Bruker’s dividend payout ratio (DPR) is presently 7.27%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on BRKR. Stifel Nicolaus lowered their price objective on shares of Bruker from $81.00 to $77.00 and set a hold rating for the company in a research report on Monday, May 20th. TD Cowen reduced their price objective on Bruker from $74.00 to $72.00 and set a hold rating on the stock in a research report on Wednesday. Jefferies Financial Group initiated coverage on Bruker in a research report on Monday, June 3rd. They issued a buy rating and a $85.00 target price for the company. StockNews.com cut Bruker from a buy rating to a hold rating in a report on Tuesday, May 21st. Finally, Bank of America cut their target price on shares of Bruker from $95.00 to $90.00 and set a buy rating on the stock in a research report on Monday, May 20th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of Hold and an average target price of $80.80.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.